Sonoma Pharmaceuticals, Inc. (SNOA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$7.50M2012: -$6.47M2013: -$3.37M2014: -$6.05M2015: -$6.66M2016: -$14.71M2017: -$12.97M2018: -$14.19M2019: -$11.26M2020: -$7.39M2021: -$3.45M2022: -$5.89M2023: -$4.57M2024: -$4.70M2025: -$3.71M2026: -$2.46M-$2.46M
2011Operating Income (USD)2026
Fiscal YearOperating IncomeChange YoY
2026-$2.46M+33.7%
2025-$3.71M+21.1%
2024-$4.70M-2.9%
2023-$4.57M+22.4%
2022-$5.89M-70.7%
2021-$3.45M+53.3%
2020-$7.39M+34.4%
2019-$11.26M+20.7%
2018-$14.19M-9.4%
2017-$12.97M+11.8%
2016-$14.71M-121.0%
2015-$6.66M-10.0%
2014-$6.05M-79.3%
2013-$3.37M+47.8%
2012-$6.47M+13.8%
2011-$7.50M